Atsuhiro Masada

Phase Ib/II Trial of NC-6004 (Nanoparticle Cisplatin) Plus Gemcitabine in Patients with Advanced Solid Tumors

Vivek Subbiah, Juneko E. Grilley‐Olson, Austin J. Combest et al. · Clinical Cancer Research · 2017 · 107 citations

NC-6004 Phase I study in combination with gemcitabine for advanced solid tumors and population PK/PD analysis

Toshihiko Doi, Tetsuya Hamaguchi, Kohei Shitara et al. · Cancer Chemotherapy and Pharmacology · 2017 · 32 citations · Full text

Mechanism of the lipid-lowering effect of ethyl all-cis-5,8,11,14,17-icosapentaenoate

Kiyoshi Mizuguchi, Takashi Yano, Yasuo Tanaka et al. · European Journal of Pharmacology · 1993 · 30 citations

Biochemistry, Organic Chemistry, Lipid Science +3

Hypolipidemic Effect of Ethyl all-cis-5,8,11,14,17-Icosapentaenoate (EPA-E) in Rats.

Kiyoshi Mizuguchi, Takashi Yano, Masahiro Kojima et al. · The Japanese Journal of Pharmacology · 1992 · 18 citations · Full text

Metabolic Syndrome, Triton Wr-1339, Biochemistry +14

Ethyl all-cis-5,8,11,14,17-icosapentaenoate modifies the biochemical properties of rat very low-density lipoprotein

Kiyoshi Mizuguchi, Takashi Yano, Masaaki Ishibashi et al. · European Journal of Pharmacology · 1993 · 17 citations

Lipid Analysis, Ethyl All-cis-5,8,11,14,17-icosapentaenoate Modifies, Lipid Synthesis +7